Good morning, everyone, and welcome, everyone, to the Prelude Therapeutics Investor Conference Call. Today's call is being recorded and is expected to last up to 45 minutes. At this time, I will now ...

Unlocking Investment Wins In The Evolving Security Stock Landscape. Investorideas ( Newswire) a leader in retail investor trading ideas for AI and cybersecurity stocks issues a snapshot of news and ...

Fees are ( (UNHANDLED TYPE: NoneType for 'None')) compared to funds in the same category. Regan Total Return Income Fund has an expense ratio of 1.48 percent. Risk is Above Average compared to funds ...

Acquired exclusive global rights to LYL273, a novel GCC-targeted CAR T-cell product candidate that has demonstrated a 67% ...